Assessment of the therapists’ basic knowledge of chronic obstructive pulmonary disease: Results of the ASCO-II project

DOI: https://doi.org/10.29296/25877305-2018-12-11
Download full text PDF
Issue: 
12
Year: 
2018

R. Bontsevich(1), Candidate of Medical Sciences; T. Filinichenko(1); A. Gavrilova(1); G. Prozorova(2), MD; O. Kompaniets(3), Candidate of Medical Sciences; N. Zubareva(4); T. Shagieva(5); E. Luchinina(6), Candidate of Medical Sciences; Professor A. Kirichenko(7), MD; E. Ebzeeva(7), Candidate of Medical Sciences; I. Galkina(8), Candidate of Medical Sciences; V. Barysheva(9), Candidate of Medical Sciences; Professor G. Ketova(9), MD; O. Osipova(1), MD; E. Milyutina(1) 1-Belgorod State National Research University; 2-N.N. Burdenko Voronezh State Medical University; 3-Kuban State Medical University, Krasnodar; 4-S.V. Ochapovsky Territorial Clinical Hospital One, Krasnodar; 5-City Clinical Hospital One, Belgorod; 6-V. I. Razumovsky Saratov State Medical University; 7-Russian Medical Academy of Continuing Professional Education, Moscow; 8-Out-patient Clinic Six, Smolensk; 9-South Ural State Medical University, Chelyabinsk

Chronic obstructive pulmonary disease (COPD) has become a global public health problem in recent decades, being one of the leading causes of death in the world. According to recently published data, the global COPD mortality rate remained virtually unchanged during 1990 to 2010: the average annual number of COPD deaths varies between 3 and 2.8 million [1]. In addition, COPD is the only disease, the deaths from which continue to increase: an average of 5–7 new cases per each 30–45 COPD-related deaths per year [2]. According to the WHO estimates, by 2020, COPD will rank third in the structure of mortality, surpassing all respiratory diseases [3]. This problem is especially urgent for Russia. Severe climatic conditions (in Western and Eastern Siberia), increasing public propensity for tobacco smoking, frequent respiratory infections, and the impact of professional pollutants on the body are the main factors predisposing to the development of COPD. Despite the development of the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), the importance of which is difficult to overestimate, there is a clear need for a more in-depth analysis of all aspects of the disease.
Keywords: 
pulmonology
chronic obstructive pulmonary disease
physicians
bronchodilator therapy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Klinicheskie rekomendatsii Rossijskogo respiratornogo obschestva po hronicheskoj obstruktivnoj bolezni legkih, 2016.
  2. Pronina E.Ju. Vershina ajsberga: epidemiologija HOBL (Obzor literatury) // Vestnik sovrem. klin. med. – 2011; 4 (3): 18–23.
  3. Shul'min A.V., Demko I.V., Dobretsova E.A. i dr. Organizatsija meditsinskoj pomoschi bol'nym s hronicheskoj obstruktivnoj bolezn'ju legkih // Sib. meditsinskoe obozrenie. – 2012; 2: 83–7.
  4. Belevskij A. Problema HOBL esche ne reshena, no nashi vozmozhnosti rasshirilis' // Remedium. – 2013; 5: 34–5.
  5. Global'naja strategija diagnostiki, lechenija i profilaktiki hronicheskoj obstruktivnoj bolezni legkih (peresmotr 2014 g.). Per. s angl. pod red. A.S. Belevskogo / M.: Rossijskoe respiratornoe obschestvo, 2014; 92 s., il.
  6. Bontsevich R., Schurovskaya K., Pokrovskaia T. et al. Assessment of senior medical students in the field of COPD (ASCO project). Update 2016 // Eur. Respir. J. – 2017; 52 (Suppl. 61): 2768.
  7. Bontsevich R., Shchurovskaya K., Pokrovskaia T. et al. Assessment of senior medical students in the field of COPD (ASCO project) // Respirology. – 2015; 20: 53.
  8. Bontsevich R.A., Schurovskaja K.V., Pokrovskaja T.G. i dr. Otsenka bazovyh znanij v voprosah HOBL u studentov starshih kursov – final'nye rezul'taty issledovanija ASCO // Farmateka. – 2018; 8: 76–81. DOI: https: //dx.doi.org/10.18565/pharmateca.2018.8.00-00
  9. Global Initiative for Chronic Obstructive Lung Disease / Pocket guide to COPD diagnosis, management, and prevention, 2017; 39 p.
  10. Chebykina A.V., Kostinov M.P. Rol' vaktsinatsii protiv grippa v profilaktike obostrenij hronicheskoj obstruktivnoj bolezni legkih // Prakticheskaja pul'monologija. – 2012; 4: 3–5.
  11. Stepanjan I.E. Spiriva® Respimat® – preparat novogo pokolenija // Rus. med. zhurn. – 2012; 6: 324.
  12. Respiratornaja meditsina: rukovodstvo: v 3 t. Pod red. A.G. Chuchalina, 2-e izd., pererab. i dop. / M.: Litterra, 2017; T. 1; 640 s.
  13. Shmelev E.I. HOBL: kljuchevye problemy // Prakticheskaja pul'monologija. – 2003; 2: 5–9. URL: https://cyberleninka.ru/article/n/hobl-klyuchevye-problemy (data obraschenija: 22.09.2018).